Paul Weiss
Directeur/Membre du Conseil chez Neurovance, Inc.
Profil
Paul Weiss is a Managing Director of Venture Investors Health Fund and is located in Madison, Wisconsin.
Paul joined Venture Investors in 2006, bringing 20-plus years of operating experience in the biotech and pharmaceutical industries.
Paul leverages this experience by focusing on investment prospects in biopharma, diagnostics, and devices when there is overlap with biopharma.
Paul serves on the Board of Directors of Invenra, Iterion Therapeutics, FluGen, and Madison Vaccines.
He is a former board member and current shareholder representative of Neurovance (spun out of Euthymics and sold to Otsuka for up to $1 billion), Aerpio Pharmaceuticals (spun out of Akebia, NASDAQ:ARPO, now Aadi Bioscience, NASDAQ:AADI), Akebia Therapeutics (NASDAQ:AKBA), and Tissue Regeneration Systems.
Prior to joining Venture Investors, Paul served as President of the Gala Biotech business unit of Cardinal Health (now the biologics division of Catalent Pharma Solutions), a division that was established when the Venture Investors portfolio company, Gala Design, Inc., under his leadership as CEO was acquired by Cardinal Health.
Prior to joining Gala, Paul served as VP of Business Development of 3-Dimensional Pharmaceuticals, a venture capital backed biotechnology company with a drug discovery platform that successfully completed an IPO during his tenure with the company and was subsequently acquired by Johnson & Johnson.
Prior to that, Paul worked as Director of Licensing for Wyeth-Ayerst (now part of Pfizer).
Postes actifs de Paul Weiss
| Sociétés | Poste | Début |
|---|---|---|
Venture Investors LLC
 Venture Investors LLC Investment ManagersFinance Venture Investors LLC (Venture Investors) is a venture capital firm founded in 1984. The firm is headquartered in Madison, Wisconsin. | Private Equity Investor | 01/01/2006 |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | 01/01/2013 |
FluGen, Inc.
 FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | - |
Invenra, Inc.
 Invenra, Inc. Pharmaceuticals: MajorHealth Technology Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI. | Directeur/Membre du Conseil | - |
University of Wisconsin Biotechnology Center
 University of Wisconsin Biotechnology Center Miscellaneous Commercial ServicesCommercial Services The University of Wisconsin Biotechnology Center provides core facilities for various biotechnology services such as bioinformatics, next-generation sequencing, genome editing, animal models, gene expression, mass spectrometry, and isotope ratio mass spectrometry. The center is based in Madison, WI. The center also offers outreach programs such as Biogarage and Biotrek. Payment instructions are included on the invoice for external customers. | Consultant / Advisor | - |
Anciens postes connus de Paul Weiss
| Sociétés | Poste | Fin |
|---|---|---|
| AERPIO PHARMACEUTICALS | Directeur/Membre du Conseil | 20/06/2018 |
Caden Biosciences, Inc.
 Caden Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Caden Biosciences, Inc. develops assays for G-protein coupled receptors. It serves the pharmaceutical industries. The company was founded in 2000 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | 10/09/2009 |
Gala Biotech
 Gala Biotech Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., Gala Biotech develops gene insertion technology to produce pharmaceutical proteins. The company is based in Middleton, WI. Gala Biotech was acquired by Cardinal Health, Inc. on October 01, 2003 for $15.50 million. | President | 01/10/2007 |
| ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Paul Weiss
| University of Wisconsin | Doctorate Degree |
| Carleton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 20 |
|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Mithridion, Inc.
 Mithridion, Inc. Pharmaceuticals: MajorHealth Technology Mithridion, Inc. develops and manufactures biopharmaceutical products. Its drugs are used for the treatment of Alzheimer's's disease and schizophrenia. The company was founded on November 19, 2004 and is headquartered in Madison, WI. | Health Technology |
Caden Biosciences, Inc.
Caden Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Caden Biosciences, Inc. develops assays for G-protein coupled receptors. It serves the pharmaceutical industries. The company was founded in 2000 and is headquartered in Madison, WI. | Health Technology |
FluGen, Inc.
FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Health Technology |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
Invenra, Inc.
Invenra, Inc. Pharmaceuticals: MajorHealth Technology Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI. | Health Technology |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Venture Investors LLC
Venture Investors LLC Investment ManagersFinance Venture Investors LLC (Venture Investors) is a venture capital firm founded in 1984. The firm is headquartered in Madison, Wisconsin. | Finance |
Gala Biotech
Gala Biotech Pharmaceuticals: MajorHealth Technology Part of Cardinal Health, Inc., Gala Biotech develops gene insertion technology to produce pharmaceutical proteins. The company is based in Middleton, WI. Gala Biotech was acquired by Cardinal Health, Inc. on October 01, 2003 for $15.50 million. | Health Technology |
Scientific Protein Laboratories LLC
 Scientific Protein Laboratories LLC Pharmaceuticals: MajorHealth Technology Scientific Protein Laboratories LLC supplies pharmaceutical ingredients. It specializes in cGMP biopharmaceutical manufacturing and commercial supplies. The firm serves the pharmaceutical, veterinary, and food industries. It offers fermentation, natural product extractions, heparin derivatives, and recovery and purification. The company founded in 1976 and is headquartered in Waunakee, WI. | Health Technology |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
ProCertus BioPharm, Inc.
 ProCertus BioPharm, Inc. Pharmaceuticals: MajorHealth Technology ProCertus BioPharm, Inc. operates as an oncology-based pharmaceutical company. Its product includes DermX, ProDermaCel, and OralX, proprietary pharmaceuticals which are designed to reduce or eliminate the side effects associated with cancer therapy. ProDermaCel will protect cancer patients from chemotherapy- and radiotherapy-induced alopecia (hair loss), DermX will prevent radiotherapy-induced dermatitis (skin burn), and OralX will protect against chemotherapy- and radiotherapy-induced oral mucositis. The company was founded by William E. Fahl and in 1997 and is headquartered in Madison, WI. | Health Technology |
Tissue Regeneration Systems, Inc.
 Tissue Regeneration Systems, Inc. BiotechnologyHealth Technology Tissue Regeneration Systems, Inc. is a medical device company commercializing a skeletal reconstruction and bone regeneration technology platform. Its platform has two novel and proprietary components, which include scaffold technology and coating technology. The company was founded by James R. Adox, Stephen E. Feinberg, William L. Murphy, Frank La Marca, and Scott Hollister in January 2005 and is headquartered in Plymouth, MI. | Health Technology |
| Columbia Research Laboratories, Inc. | |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Madison Vaccines, Inc.
Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Health Technology |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. The firm's product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company was founded by Joseph H. Garder on November 16, 2007 and is headquartered in Cincinnati, OH. | Health Technology |
University of Wisconsin Biotechnology Center
University of Wisconsin Biotechnology Center Miscellaneous Commercial ServicesCommercial Services The University of Wisconsin Biotechnology Center provides core facilities for various biotechnology services such as bioinformatics, next-generation sequencing, genome editing, animal models, gene expression, mass spectrometry, and isotope ratio mass spectrometry. The center is based in Madison, WI. The center also offers outreach programs such as Biogarage and Biotrek. Payment instructions are included on the invoice for external customers. | Commercial Services |